Cite
HARVARD Citation
Rugo, H. et al. (2021). PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer. Journal of the National Cancer Institute. pp. 1733-1743. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rugo, H. et al. (2021). PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer. Journal of the National Cancer Institute. pp. 1733-1743. [Online].